Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.

Also called NCT01550588

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Jae-Kwan Song (from the registry)
Registry
  • NCT NCT01550588
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01550588. Randomized; single masking; primary purpose prevention. Start 2012-02 (registry gives no type); primary completion 2020-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)
Condition
Patent Foramen Ovale
Intervention (Device)
Device closure
Intervention (Drug)
Standard medical treatment
Lead sponsor
Jae-Kwan Song (class: other)

Record details

Record id
cardio:ct-nct01550588
Content hash
8f0ec1aebd3bd46e20a724fe880e4346b4970b67587dd5a8be7554f2cef2bdf9